Andrew Hattersley Selected Research

Andrew Hattersley Research Topics

6	Type 2 Diabetes Mellitus (MODY) 12/2020 - 06/2014
2	Genetic Risk Score 01/2022 - 01/2019
1	Insulin Resistance 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Disease Progression 01/2022
1	Deafness (Deaf Mutism) 01/2022
1	Obesity 01/2022
1	Neoplasms (Cancer) 01/2022
1	Lipodystrophy 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Prediabetic State (Prediabetes) 01/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 07/2017
1	Diabetes Mellitus 01/2017
1	Hypoglycemia (Reactive Hypoglycemia) 12/2014
1	Fetal Macrosomia 12/2014
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 05/2012
1	Ketosis 03/2011
1	Permanent Neonatal Diabetes Mellitus 03/2011
1	Hyperglycemia 03/2011
1	Hypertension (High Blood Pressure) 05/2003

6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2012
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2014
2	Pharmaceutical PreparationsIBA 12/2020 - 12/2014
2	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 05/2003
2	Insulin (Novolin)FDA Link 01/2019 - 07/2017
1	Serine (L-Serine)FDA Link 01/2022
1	Exonucleases (3' 5' Exonuclease)IBA 01/2022
1	HDL LipoproteinsIBA 01/2021
1	2,4-thiazolidinedione (thiazolidinedione)IBA 12/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2020
1	Metformin (Glucophage)FDA LinkGeneric 12/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2020
1	AntigensIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	C-PeptideIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 10/2017
1	GlucokinaseIBA 10/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Glyburide (Glibenclamide)FDA LinkGeneric 12/2014
1	KATP ChannelsIBA 03/2011
1	Adenosine Triphosphate (ATP)IBA 03/2011

4	Therapeutics 12/2020 - 05/2003